Revision of immunosuppression in a solid organ transplant recipient leads to complete remission of metastatic undifferentiated carcinoma

Abigail H Waldman; Jennifer M McNiff; AnnMarie Liapakis; William S Asch; Stephanie Smith-Marrone; Oscar R Colegio

doi:10.1016/j.jdcr.2015.09.010

Revision of immunosuppression in a solid organ transplant recipient leads to complete remission of metastatic undifferentiated carcinoma

JAAD Case Rep. 2015 Nov 24;1(6):S8-S11. doi: 10.1016/j.jdcr.2015.09.010. eCollection 2015 Nov.

Authors

Abigail H Waldman¹, Jennifer M McNiff², AnnMarie Liapakis³, William S Asch³, Stephanie Smith-Marrone⁴, Oscar R Colegio⁵

Affiliations

¹ Yale Transplant Dermatology Clinic, New Haven, Connecticut.
² Yale Department of Dermatology, New Haven, Connecticut.
³ Yale-New Haven Transplantation Center, New Haven, Connecticut.
⁴ Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, Sleepy Hollow, New York.
⁵ Yale Transplant Dermatology Clinic, New Haven, Connecticut; Yale Department of Dermatology, New Haven, Connecticut; Yale-New Haven Transplantation Center, New Haven, Connecticut; Yale Cancer Center, New Haven, Connecticut.

No abstract available

Keywords: PET, positron emission tomography; PI3K, phosphatidylinositol-3 kinase; SCC, squamous cell carcinoma; SOTR, solid organ transplant recipient; calcineurin inhibitor; mTOR, mammalian target of rapamycin; mammalian target of rapamycin inhibitor; rapamycin; sirolimus; tacrolimus; undifferentiated carcinoma.

Publication types

Case Reports